Piramal Pharma Ltd.

NSE: PPLPHARMASmall Cap Pharmaceuticals

₹188.51+0 (+0%)

Last updated: 21 Nov, 2025, 02:09 PM

PPLPHARMA Income statement

All values in ₹ Cr.

	FY 25	FY 24	FY 23	FY 22	FY 21
Sales	9,151	8,171	7,082	6,559	6,315
Expenses	7,706	6,975	6,453	5,609	4,887
Operating Profit	1,445	1,196	628.24	949.66	1,428
OPM %	15.56	14.33	8.60	13.89	22.04
Other Income	134.81	112.60	218.15	260.72	182.34
EBITDA	1,580	1,372	853.35	1,225	1,592
Interest	421.59	448.49	344.18	198.25	163.45
Depreciation	816.34	740.57	676.69	586.18	545.04
Profit Before Tax	341.71	119.80	-174.48	425.95	901.81
Tax %	94.67	134.78	-38	25.59	12.64
Net Profit	91.13	17.82	-186.46	375.96	835.03
EPS	0.69	0.13	-1.56	3.17	8.40
Dividend Payout %	20.29	84.62	0	0	0

PPLPHARMA Balance sheet

All values in ₹ Cr.

	FY 25	FY 24	FY 23	FY 22	FY 21
Equity Capital	1,324	1,323	1,193	1,186	994.60
Reserves	6,801	6,588	5,580	5,511	4,610
Minority Interest	--	--	--	--	--
Non Current Liabilities	3,786	3,031	3,906	3,067	2,805
Current Liabilities	3,766	4,369	3,843	3,033	2,490
Total Liabilities	15,678	15,312	14,523	12,797	10,900
Non Current Assets	9,881	9,847	9,687	8,730	7,251
Current Assets	5,797	5,464	4,835	4,067	3,649
Total Assets	15,678	15,312	14,523	12,797	10,900
Contingent Liabilities	925.66	288.52	305.78	365.47	203.55

PPLPHARMA Cash flow

All values in ₹ Cr.

	FY 25	FY 24	FY 23	FY 22	FY 21
Cash from Operating Activity	892.30	1,005	483.89	766.42	597.58
Cash from Investment Activity	-477.46	-434.01	-1,339	-1,812	-4,480
Cash from Financing Activity	-440.83	-422.36	817.79	794.19	3,977
Net Cash Flow	-36.87	165.96	-31.95	-176.79	110.02

PPLPHARMA Ratio Analysis

	FY 25	FY 24	FY 23	FY 22	FY 21
Basic EPS (₹)	0.69	0.13	-1.56	3.17	8.40
Diluted EPS (₹)	0.68	0.14	-1.57	3.19	18.56
Cash EPS (₹)	6.85	5.73	4.11	8.11	13.88
Book Value Per Share (₹)	61.35	59.80	56.76	56.47	56.35
Dividend Per Share	0.14	0.11	0	0	0
Cash Flow Per Share	6.74	7.59	4.05	6.46	6.01
Current Ratio	1.54	1.25	1.26	1.34	1.47

Download Mobile Apps

© Copyright 2025 etmoney.com All Rights Reserved

Disclaimer: Investment in securities market are subject to market risks. Read all the related documents carefully before investing.

Banayantree Services Limited, Non-Individual SEBI Registered Investment Advisers, RIA No. INA100006898, Validity January 09, 2017 - Perpetual

Registered Address: Express Building, 9-10, Bahadurshah Zafar Marg, New Delhi - 110002

Corporate Office: Plot No. 391, Udyog Vihar, Phase-III, Gurugram, Haryana, 122016

Email Id - help@etmoneycare.com Email Id of Principal Officer - po@etmoney.com

SEBI Corporate Office:NBCC Complex, Office Tower-1, 8th Floor, Plate B, East Kidwai Nagar, New Delhi - 110023